Synovial Fibroblast 1: Secretion response of primary human synovial fibroblast samples from one healthy and one rheumatoid arthritis donor to a panel of 10 stimuli and 10 small molecule inhibitors - Dataset (ID:20233)
- Detail
- Small Molecules Studied
- Primary Cells Studied
- Proteins Studied
- Unclassified Perturbagens Studied
- Data Columns
- Results
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Protein Stimulus | Other Stimulus | Stimulus Concentration | Stimulus Conc Unit | ExpPlate | Measured Protein | Measured Protein MFI (a.u.) | Bead Count |
---|---|---|---|---|---|---|---|---|---|---|---|
N2586 | PI103 | 0.1 | uM | 3 | VEGF | 1259.0 | 77 | ||||
0 | VEGF | 57.5 | 54 | ||||||||
RA2159 | TNF-a | 100 | ng/mL | 3 | VEGF | 1038.0 | 55 | ||||
RA2159 | PD184352 | 0.1 | uM | TNF-a | 100 | ng/mL | 3 | VEGF | 1051.0 | 59 | |
RA2159 | Lestaurtinib | 0.3 | uM | TNF-a | 100 | ng/mL | 3 | VEGF | 733.0 | 61 | |
RA2159 | Ruxolitinib | 0.3 | uM | TNF-a | 100 | ng/mL | 3 | VEGF | 1047.5 | 76 | |
RA2159 | Tofacitinib | 0.3 | uM | TNF-a | 100 | ng/mL | 3 | VEGF | 927.5 | 68 | |
RA2159 | IKK16 | 2.0 | uM | TNF-a | 100 | ng/mL | 3 | VEGF | 890.0 | 71 | |
RA2159 | EO1428 | 1.0 | uM | 3 | VEGF | 729.0 | 49 | ||||
N2586 | TNF-a | 100 | ng/mL | 3 | VEGF | 1524.0 | 69 | ||||
N2586 | PD184352 | 0.1 | uM | TNF-a | 100 | ng/mL | 3 | VEGF | 1125.0 | 49 | |
N2586 | Lestaurtinib | 0.3 | uM | TNF-a | 100 | ng/mL | 3 | VEGF | 1192.0 | 65 | |
N2586 | Ruxolitinib | 0.3 | uM | TNF-a | 100 | ng/mL | 3 | VEGF | 22.0 | 56 | |
N2586 | Tofacitinib | 0.3 | uM | TNF-a | 100 | ng/mL | 3 | VEGF | 1659.0 | 39 | |
N2586 | IKK16 | 2.0 | uM | TNF-a | 100 | ng/mL | 3 | VEGF | 1674.0 | 59 | |
N2586 | EO1428 | 1.0 | uM | 3 | VEGF | 1435.5 | 56 | ||||
0 | VEGF | 38.0 | 49 | ||||||||
RA2159 | 3 | VEGF | 764.0 | 69 | |||||||
RA2159 | PD184352 | 0.1 | uM | 3 | VEGF | 990.0 | 51 | ||||
RA2159 | Lestaurtinib | 0.3 | uM | 3 | VEGF | 873.0 | 70 | ||||
RA2159 | Ruxolitinib | 0.3 | uM | 3 | VEGF | 832.0 | 65 | ||||
RA2159 | Tofacitinib | 0.3 | uM | 3 | VEGF | 844.5 | 46 | ||||
RA2159 | IKK16 | 2.0 | uM | 3 | VEGF | 809.0 | 73 | ||||
RA2159 | 3 | VEGF | 830.5 | 62 | |||||||
N2586 | 3 | VEGF | 1644.0 | 66 |